Concepedia

Joel Iff

JI

4

Publications

69

Citations

4

H-Index

2021

Active since

Affiliations

Sarepta Therapeutics (United States)(Current)

Analysis Group (United States)

University of California Davis Medical Center

University of California, Davis

Joel Iff is an author at Sarepta Therapeutics (United States) specializing in health informatics, diagnosis, and medicine.

Top concepts

Publications per year

2021–2024

4

Publications

4

Disease Progression Stages and Burden in Patients with Duchenne Muscular Dystrophy Using Administrative Claims Supplemented by Electronic Medical Records

Joel Iff, Yi Zhong, Deepshekhar Gupta et al. · Advances in Therapy · 2022 · 21 citations

, , +7

Delays in pulmonary decline in eteplirsen‐treated patients with <scp>Duchenne</scp> muscular dystrophy

Joel Iff, C. Gerrits, Yi Zhong et al. · Muscle & Nerve · 2022 · 19 citations · Full text

Survival among patients receiving eteplirsen for up to 8 years for the treatment of <scp>Duchenne</scp> muscular dystrophy and contextualization with natural history controls

Joel Iff, Nicolae Done, Edward Tuttle et al. · Muscle & Nerve · 2024 · 18 citations · Full text

Rasch Analysis of the Pediatric Quality of Life Inventory 4.0 Generic Core Scales Administered to Patients With Duchenne Muscular Dystrophy

Erik Landfeldt, Joel Iff, Erik Henricson et al. · Value in Health · 2021 · 11 citations · Full text

Rows per page

1–4 of 4